Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Belen Sadaba"'
Autor:
Carlos Chaccour, Paula Ruiz-Castillo, Mary-Ann Richardson, Gemma Moncunill, Aina Casellas, Francisco Carmona-Torre, Miriam Giráldez, Juana Schwartz Mota, José Ramón Yuste, José Ramón Azanza, Miriam Fernández, Gabriel Reina, Carlota Dobaño, Joe Brew, Belen Sadaba, Felix Hammann, Regina Rabinovich
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-4 (2020)
Abstract Objectives The primary objective is to determine the efficacy of a single dose of ivermectin, administered to low risk, non-severe COVID-19 patients in the first 48 hours after symptom onset to reduce the proportion of patients with detectab
Externí odkaz:
https://doaj.org/article/d7c0183d2e3843dbb71c302b19ff9439
Autor:
Carlos Chaccour, Aina Casellas, Andrés Blanco-Di Matteo, Iñigo Pineda, Alejandro Fernandez-Montero, Paula Ruiz-Castillo, Mary-Ann Richardson, Mariano Rodríguez-Mateos, Carlota Jordán-Iborra, Joe Brew, Francisco Carmona-Torre, Miriam Giráldez, Ester Laso, Juan C. Gabaldón-Figueira, Carlota Dobaño, Gemma Moncunill, José R. Yuste, Jose L. Del Pozo, N.Regina Rabinovich, Verena Schöning, Felix Hammann, Gabriel Reina, Belen Sadaba, Mirian Fernández-Alonso
Publikováno v:
EClinicalMedicine, Vol 32, Iss , Pp 100720- (2021)
Background: Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not readily achievable with currently approved doses. There is limited evidence to support its clinical use in COVID-19 patients. We conducted a Pilot, randomize
Externí odkaz:
https://doaj.org/article/3566a7f25e3a4af994af0f2ba472a486
Autor:
Belen Sadaba, Anabel del Barrio, Miguel Angel Campanero, Jose Ramon Azanza, Almudena Gomez-Guiu, Jose Maria Lopez-Picazo, Salvador Martin Algarra, Francisco Guillén Grimá, Maria Blanco Prieto, Jose Luis Perez-Gracia, Alfonso Gurpide
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89747 (2014)
Palonosetron is a potent second generation 5- hydroxytryptamine-3 selective antagonist which can be administered by either intravenous (IV) or oral routes, but subcutaneous (SC) administration of palonosetron has never been studied, even though it co
Externí odkaz:
https://doaj.org/article/732bd83ce7fe475ebabe0fd50f2fd1e3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Carlos Chaccour, Aina Casellas, Andres Blanco-Di Matteo, Iñigo Pineda, Alejandro Fernandez-Montero, Paula Ruiz Castillo, Mary-Ann Richardson, Mariano Rodriguez Mateos, Carlota Jordan-Iborra, Joe Brew, Francisco Carmona-Torre, Miriam Giraldez, Ester Laso, Carlota Dobaño, Gemma Moncunill, Jose R Yuste, Jose L Del Pozo, Regina Rabinovich, Verena Schoening, Felix Hammann, Gabriel Reina, Belen Sadaba, Miriam Fernandez-Alonso
Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not readily achievable with currently approved doses. There is limited evidence to support its clinical use in COVID-19 patients. We conducted a Pilot, randomized, double-bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00ab1ec7b3d4e7737bd2e14842682434
https://doi.org/10.21203/rs.3.rs-116547/v1
https://doi.org/10.21203/rs.3.rs-116547/v1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.